Navigation Links
Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
Date:8/29/2007

BOCA RATON, Fla., Aug. 29 /PRNewswire/ -- Dawson James Securities, a full- service investment firm serving the healthcare and biotechnology industry, initiated research coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy rating and a 12-18 month price target of $6.00. John M. Putnam, Sr. VP-Medical Devices, issued the report.

The report describes CryoCor's recently FDA-approved cryoablation system for atrial flutter and their current pivotal trial for atrial fibrillation. Mr. Putnam states "With the FDA's approval of CryoCor's cryoablation system for the treatment of atrial flutter, and the strong prospect of an approval for treating the much larger indication of atrial fibrillation in 2008, we believe the company is on the verge of meaningful revenue generation."

A copy of the report may be obtained by contacting Dawson James Securities at 561-391-5555.

About Dawson James Securities:

Dawson James Securities is a full service investment firm with deep expertise in healthcare and biotechnology and having a staff of over 50 investment professionals providing institutional research, investment banking and high net worth services to our clients. More information is available at http://www.DawsonJames.com

Disclosures:

Dawson James has not acted as an investment banker for the company mentioned in this report in the past, although Dawson James may have sought in the past, or may actively seek in the future, compensation for investment banking services. Dawson James and/or its directors and employees may own securities in the companies and may increase or decrease holdings in the future.

The analyst certifies that 1) all of the views expressed accurately reflect his personal views about any and all of the subject securities or issuers discussed; and 2) no part of the research analyst's compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed by the research analyst; 3) the analyst responsible for preparing this research report receives compensation based upon various factors, including total revenues of Dawson James and its affiliates, a portion of which is generated by investment banking activities and 4) the analyst and/or members of their immediate family do not own stock in the companies mentioned.

Contact:

Dawson James Securities

John M. Putnam, 561-208-2950

Fax: 561-391-5757

Dawson James Securities is a member of the National Association of Securities Dealers, CRD number 130645.


'/>"/>
SOURCE Dawson James Securities
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Germantown drug company hires pharma veteran James Davidson as COO
2. State puts up $1 million for James Thomsons new stem cell startup
3. OpGen adds Thomas Pyle and James Ogle to board of directors
4. UW stem-cell team led by James Thomson gets $1.25M private grant
5. James Thomson plans to stay in Madison to study genesis of stem cells
6. Early Stage, Step 9: Raising capital in the securities landscape
7. Securities compliance is part of raising capital
8. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
9. Quantitation of the Protein MIA as a Marker for Chondrocytes in Research Samples
10. Control Your siRNA Research
11. Getting Started with MicroRNA Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... ... Drive Precision Farming in 2017 and Beyond. The paper outlines the key trends ... precision ag industry. , “We’ve witnessed a lot of highs and lows as ...
(Date:5/23/2016)... and LONDON , May 23, 2016 /PRNewswire/ ... See Frontage Boost Efficiency by 40% - Frontage Implement ... - Frontage Enforce Quality, Compliance and Traceability Within the Bioanalytical lab ... labs in the United States and ... to be deployed across its laboratory facilities. In addition to serving ...
(Date:5/22/2016)... ... 22, 2016 , ... Doctors in Rome say micronutrients found in certain foods ... Surviving Mesothelioma has just posted an article on the new research. Click here ... Clinical Sciences and Translational Medicine evaluated more than 150 studies on polyphenols in cancer ...
(Date:5/20/2016)... ... May 20, 2016 , ... Korean researchers say Manumycin A triggers apoptosis, or ... way to treat the disease. Surviving Mesothelioma has just posted an article on the ... Korean institutions based their mesothelioma study on the fact the Manumycin A, a derivative ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
Breaking Biology News(10 mins):